muscle loss with glp 1 and GLP-1R agonists use Can You Lose Muscle on
Description
doi: 10.1111/adb.12295

[79] Trials for cardiovascular health [edit] In March 2024, the US Food and Drug Administration expanded the indication for semaglutide (brand name Wegovy) to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and who are either obese or overweight

Consequently, people who start taking GLP-1s may find themselves consuming a lot fewer calories than they had been before

Ozempic is prescribed to improve blood sugar control in adults with Type 2 diabetes mellitus